Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Johnson and Johnson
McKesson
Medtronic
Boehringer Ingelheim

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

Litigation Details for Abbott Laboratories v. Impax Laboratories Inc. (D. Del. 2007)

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Abbott Laboratories v. Impax Laboratories Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Abbott Laboratories v. Impax Laboratories Inc. (D. Del. 2007)

Date Filed Document No. Description Snippet Link To Document
2007-06-18 1 Complaint Clted U.S. PATENT DOCUMENTS 4,369,172 A 1/1983 Schor et al. 4,699,927 A 10/1987 Deboeck 4,913,906 A 4/1990… lower incidence of side effects for patients 4,913,906 A 4/1990 Friedman et ol. consuming such a formulation…formulation including sodium valproate. U.S. Pat, No. 4,913,906 to Frledrnan, et al. discloses a controlled release…formulation including sodium valproate. U.S. Pat. No. 4,913,906 to Friedman, et al discloses a controlled release… infringe the ‘086 patent and the °090 patent, but did not argue that either patent is invalid or unenforceable External link to document
2007-07-27 14 Answer to Complaint formulation including sodium valproate. U.S. Pat. No. 4,913,906 to Friedman, et al. discloses a controlled release…4,699,927 A 10/1987 Deboeck ()F ])[VALPR()EX S()])IUM 4,913,906 A 4/1990 Friedman er al. 4,988,731 A 1/1991 Meade…formulation including sodium valproate. U.S. Pat. No. 4,913,906 to Friedman, et al. discloses a controlled release…steady-state levels have been achieved This results in a 4,913,906 A 4/1990 Friedman et al. significantly lower incidence…formulation including sodium valproate. U.S. Pat. No. 4,913,906 to Friedman, et al discloses a controlled release External link to document
2007-07-30 15 Proposed Order Certiiication, i.e., U.S. Patent-Nos.~654-l*9,»9§3___~»»~~- (“the ‘953 patent”); 6,511,678 (“the ‘687 pateiit…Abbott owns certain patents, including U.S. Patent Nos. 6,'713,086 (“the ‘086 patent”) and 6,528,090 …original patents at issue, the ‘090 and ‘086 patents, as well as four additional related patents, the ‘953…090 patents Thus, linpax seeks approval to market its product prior to the expiry of these patents As…086 and ‘090 patent and added Declaratory Judgment Counterclaims against those two patents relating to External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
AstraZeneca
Boehringer Ingelheim
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.